Assignee
PIERIS AG
DE·10 granted patents·4 pending applications·469 citations·filing 1998–2016
Top patents by PatentIndex Score
14 records- 0196US7250297B1AnticalinsPIERIS AG·Filed 1998·Granted Jul 31, 2007·320 cites·5 claims
- 0292US7585940B2Muteins of human tear lipocalinPIERIS AG·Filed 2004·Granted Sep 8, 2009·41 cites·8 claims
- 0390US7723476B2AnticalinsPIERIS AG·Filed 2005·Granted May 25, 2010·11 cites·17 claims
- 0490US7252998B2Muteins of human neutrophil gelatinase-associated lipocalin and related proteinsPIERIS AG·Filed 2002·Granted Aug 7, 2007·50 cites·16 claims
- 0588US7892827B2Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4)PIERIS AG·Filed 2005·Granted Feb 22, 2011·21 cites·18 claims
- 0685US7691970B2Muteins of a bilin-binding protein with affinity for a given targetPIERIS AG·Filed 2003·Granted Apr 6, 2010·13 cites·26 claims
- 0781US7893208B2Muteins of human tear lipocalinPIERIS AG·Filed 2009·Granted Feb 22, 2011·5 cites·8 claims
- 0874US9522940B2Lipocalin muteins with binding-affinity for glypican-3 (GPC-3) and use of lipocalin muteins for target-specific delivery to cells expressing GPC-3PIERIS AG·Filed 2013·Granted Dec 20, 2016·6 cites·17 claims
- 0969US9150629B2Human tear lipocalins which bind PCSK9 and methods of use thereofPIERIS AG·Filed 2014·Granted Oct 6, 2015·1 cites·56 claims
- 1062US10064963B2Methods and compositions for treating disordersPIERIS AG·Filed 2013·Granted Sep 4, 2018·1 cites·8 claims
- 1154US2014080177A1AnticalinsPIERIS AG·Filed 2013·Application pending·0 cites
- 1248US2016280747A1AnticalinsPIERIS AG·Filed 2016·Application pending·0 cites
- 1348US2015369821A1Novel lipocalin-mutein assays for measuring hepcidin concentrationPIERIS AG·Filed 2014·Application pending·0 cites
- 1446US2015291675A1Human neutrophil gelatinase-associated lipocalin (hngal) muteins that bind hepcidin and nucleic acid encoding suchPIERIS AG·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →